Essex Investment Management »

Revance Therapeutics shares owned by Essex Investment Management

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Essex Investment Management from 13F filings

Historical chart of Essex Investment Management investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Essex Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Essex Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.1M 122k 8.79
2023-09-30 $961k 84k 11.47
2023-06-30 $2.8M 109k 25.31
2023-03-31 $3.5M 109k 32.21
2022-12-31 $1.3M 68k 18.46
2022-09-30 $1.9M 69k 27.00
2022-06-30 $879k 64k 13.82
2022-03-31 $1.3M 65k 19.50
2021-12-31 $2.1M 129k 16.32
2021-09-30 $3.7M 131k 27.86
2021-06-30 $3.9M 131k 29.64
2021-03-31 $3.9M 139k 27.95
2020-12-31 $2.2M 77k 28.34
2020-09-30 $2.5M 100k 25.14
2020-06-30 $1.6M 67k 24.43
2020-03-31 $1.5M 100k 14.80
2018-09-30 $2.2M 87k 24.85
2018-06-30 $2.4M 87k 27.45
2018-03-31 $3.4M 111k 30.80
2017-12-31 $4.3M 119k 35.75
2017-09-30 $2.9M 105k 27.55
2017-06-30 $3.3M 125k 26.40
2017-03-31 $2.1M 99k 20.80
2016-12-31 $1.9M 91k 20.70
2016-09-30 $1.4M 86k 16.21
2016-06-30 $1.1M 82k 13.60
2016-03-31 $1.4M 82k 17.45
2015-12-31 $2.4M 72k 34.16
2015-09-30 $2.1M 72k 29.76
2015-06-30 $2.3M 72k 31.98